Consequently, this gK-SPP interaction may be considered as a specific therapeutic target for the prevention of corneal infection in patients at risk and a reduction in the severity of the CS in patients who have established infections thereby providing an effective treatment for those suffering from the devastating effects of HSK. This evidence concerns the gene GK and corneal infection.